These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2328508)
1. Evidence for the role of spinal cord systems in Parkinson's disease-associated pain. Sage JI; Kortis HI; Sommer W Clin Neuropharmacol; 1990 Apr; 13(2):171-4. PubMed ID: 2328508 [TBL] [Abstract][Full Text] [Related]
2. Complex dystonia of Parkinson's disease: clinical features and relation to plasma levodopa profile. McHale DM; Sage JI; Sonsalla PK; Vitagliano D Clin Neuropharmacol; 1990 Apr; 13(2):164-70. PubMed ID: 2328507 [TBL] [Abstract][Full Text] [Related]
3. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity. Krack P; Pollak P; Limousin P; Benazzouz A; Deuschl G; Benabid AL Brain; 1999 Jun; 122 ( Pt 6)():1133-46. PubMed ID: 10356065 [TBL] [Abstract][Full Text] [Related]
4. Forms of dystonia in patients with Parkinson's disease. Kidron D; Melamed E Neurology; 1987 Jun; 37(6):1009-11. PubMed ID: 3587617 [TBL] [Abstract][Full Text] [Related]
14. Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson's disease. Melamed E Arch Neurol; 1979 May; 36(5):308-10. PubMed ID: 444100 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies to prevent motor complications in Parkinson's disease. Kieburtz K J Neurol; 2008 Aug; 255 Suppl 4():42-5. PubMed ID: 18821085 [TBL] [Abstract][Full Text] [Related]
16. Meige's syndrome during long-term dopaminergic therapy in Parkinson's disease. Weiner WJ; Nausieda PA Arch Neurol; 1982 Jul; 39(7):451-2. PubMed ID: 7103786 [No Abstract] [Full Text] [Related]
17. Morphine in tardive and idiopathic dystonia (short communication). Berg D; Becker G; Naumann M; Reiners K J Neural Transm (Vienna); 2001; 108(8-9):1035-41. PubMed ID: 11716139 [TBL] [Abstract][Full Text] [Related]
18. Sudden appearance of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease. Onofrj M; Paci C; Thomas A J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):605-6. PubMed ID: 9771801 [No Abstract] [Full Text] [Related]